Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Andrew Sherman

Thoracic Surgery (Cardiothoracic Vascular Surgery) Tampa, FL Medical Doctor

NPI 1992777551 CMS profile 226320

3003 W. Dr. Martin Luther King Jr. Blvd., Mab - 2Nd Floor, Tampa, FL 33607

Open in the dashboard

General payments

$517,239

328 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$1,040,408 paid to institutions, not to them · program years 2023–2024

Through program year 2025, Andrew Sherman of Tampa, FL is reported in the CMS Open Payments database as having received $517,239 across 328 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $1,040,408 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 98th percentile of Thoracic Surgery (Cardiothoracic Vascular Surgery) profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $123,249 57
2024 General $103,807 75
2023 General $60,332 45
2022 General $106,900 77
2021 General $39,788 36
2020 General $44,592 15
2019 General $38,572 23

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Andrew Sherman
  • Thoracic Surgery (Cardiothoracic Vascular Surgery) median
  • Middle half of Thoracic Surgery (Cardiothoracic Vascular Surgery)
  • National median

In program year 2025, general payments to Andrew Sherman were reported at $123,249. Among 4,073 Thoracic Surgery (Cardiothoracic Vascular Surgery) profiles paid that year, the median was $791 and the middle half received between $208 and $3,074.

Show as a table
Year Andrew Sherman Thoracic Surgery (Cardiothoracic Vascular Surgery) median Middle half National median
2019 $38,572 $886 $178–$3,167 $163
2020 $44,592 $341 $108–$1,605 $114
2021 $39,788 $453 $125–$1,886 $132
2022 $106,900 $695 $180–$2,566 $149
2023 $60,332 $745 $205–$2,662 $160
2024 $103,807 $799 $214–$2,967 $164
2025 $123,249 $791 $208–$3,074 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Atricure, Inc. $516,630 316 payments
  2. Edwards Lifesciences Corporation $161 2 payments
  3. Penumbra, Inc. $141 1 payment
  4. Abbott Laboratories $106 1 payment
  5. Bolton Medical Inc $60 1 payment
  6. Maquet Cardiovascular U.S. Sales, L.L.C. $43 2 payments
  7. Abiomed $38 2 payments
  8. CryoLife, Inc. $30 1 payment
  9. Integra LifeSciences Corporation $15 1 payment
  10. Bard Peripheral Vascular, Inc. $14 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $487,050 153 payments
  2. Travel and Lodging $23,031 66 payments
  3. Food and Beverage $7,159 109 payments
Products named General payments · program years 2019–2025
  1. SYNERGY ABLATION SYSTEM $216,496 136 payments
  2. EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX $182,498 127 payments
  3. ATRICLIP LAA EXCLUSION SYSTEM $41,271 38 payments
  4. EPI-SENSE GUIDED COAGULATION SYS $31,972 14 payments
  5. ISOLATOR SURGICAL ABLATION SYSTEM $17,036 9 payments
  6. AtriCure cryoICE cryoSPHERE Cryoablation System $13,826 16 payments
  7. ATRICURE SYNERGY ABLATION SYSTEM $13,000 2 payments
  8. ATRICURE CRYOICE CRYOABLATION SYSTEM (CRYO2) $4,349 8 payments
  9. FUSION ABLATION SYSTEM $2,500 1 payment
  10. DISSECTOR $812 4 payments
  11. Other $1,019 20 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 43 billing codes

Paid by Medicare

$129,559

Medicare's payments for the services billed

Medicare patients

91

Average age 72

Services billed

296

29 women, 62 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Ischemic heart disease 75%
Atrial fibrillation 59%
Arthritis 46%
Heart failure 41%
Chronic kidney disease 40%
Diabetes 37%
Depression 30%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

328 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Thoracic Surgery (Cardiothoracic Vascular Surgery) in Florida

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record